The cellular/molecular abnormalities of Alzheimer's disease are also present in older patients with Down's syndrome and in some old nondemented individuals. To evaluate these changes, it is essential to have optimally prepared tissues from clinically well-characterized cases who lack other confounding illnesses. Core C includes a staff of neuropathologists, neuroanatomists, other basic scientists, a clinical coordinator, and technical personnel. The professional staff of Core C arranges autopsies, neuropathological diagnosis, and coordinates the use of tissues for research. These scientists also direct the technical staff and laboratory facilities involved in histology, immunocytochemistry, neurochemistry, receptor autoradiography, and computer-assisted imaging (i.e., for morphometry, autoradiography, in situ hybridization, and Northern and Western blots). The clinical coordinator works with patients, families, and clinicians to facilitate autopsies. The technical staff assists with autopsy procedures and brain dissections, performs histological processing and staining of diagnostic and research material, accessions and stores tissues for distribution to investigators, assists with preparation of tissues or neurochemical and autoradiographic studies, and maintains and operates the image analysis systems. Finally, members of the Core C staff participate in projects of the Consorium to Establish a Registry for Alzheimer's Disease (CERAD) and contribute significantly to the training of physicians and scientists on issues relevant to aging, Alzheimer's disease, and Down's syndrome.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-10
Application #
3790133
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Bouhrara, Mustapha; Reiter, David A; Bergeron, Christopher M et al. (2018) Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimers Dement 14:998-1004
Xiong, Yulan; Neifert, Stewart; Karuppagounder, Senthilkumar S et al. (2018) Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc Natl Acad Sci U S A 115:1635-1640
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6
Wong, Dean F; Comley, Robert A; Kuwabara, Hiroto et al. (2018) Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects. J Nucl Med 59:1869-1876
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Varma, Vijay R; Oommen, Anup M; Varma, Sudhir et al. (2018) Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med 15:e1002482
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Soldan, Anja; Pettigrew, Corinne; Albert, Marilyn (2018) Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. Psychiatr Clin North Am 41:65-77
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Bermudez, Camilo; Plassard, Andrew J; Davis, Taylor L et al. (2018) Learning Implicit Brain MRI Manifolds with Deep Learning. Proc SPIE Int Soc Opt Eng 10574:

Showing the most recent 10 out of 830 publications